InfuSystem Holdings (INFU) Capital Expenditures (2010 - 2026)

InfuSystem Holdings has reported Capital Expenditures for 17 years, with the latest figure at $157000.0 in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures rose 19.85% year-over-year to $157000.0; the trailing twelve-month figure through Mar 2026 stood at $586000.0 (down 43.71% YoY), and the FY2025 full-year result was $560000.0, down 48.72% from the prior year.
• Capital Expenditures for Q1 2026 stood at $157000.0, up from $133000.0 in the prior quarter.
• The five-year high for Capital Expenditures was $530000.0 in Q4 2024, with the low at -$367000.0 in Q4 2023.
• Historically, Capital Expenditures has averaged $178823.5 across 5 years, with a median of $177000.0 in 2023.
• Annual changes were most pronounced in 2023 — Capital Expenditures tumbled 189.29% — and 2024, when it surged 244.41%.
• InfuSystem Holdings' Capital Expenditures stood at $411000.0 in 2022, then slumped by 189.29% to -$367000.0 in 2023, then surged by 244.41% to $530000.0 in 2024, then plunged by 74.91% to $133000.0 in 2025, then gained by 18.05% to $157000.0 in 2026.
• The last three Capital Expenditures figures came in at $157000.0 (Q1 2026), $133000.0 (Q4 2025), and $79000.0 (Q3 2025), per Business Quant data.